Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Advances in Pharmacology (San Diego, Calif.)
|
February 10, 2025
Inhibition of brain glutamate carboxypeptidase II (GCPII) to enhance cognitive function
Robyn Wiseman, Kristin L Bigos, Amy F T Arnsten, et al.
Research Square
|
November 21, 2023
Nelfinavir Inhibition of Kaposi's sarcoma-associated herpesvirus protein expression and capsid assembly
Maggie Li, Barbara Smith, Lee Jaeyeun, et al.
Behavioural Processes
|
September 6, 2023
Degrading stimuli by reducing image resolution impairs performance in a rodent continuous performance test
Adrienne C DeBrosse, Ye Li, Robyn Wiseman, et al.
Infectious Agents and Cancer
|
March 4, 2024
Nelfinavir inhibition of Kaposi's sarcoma-associated herpesvirus protein expression and capsid assembly
Maggie Li, Barbara J Smith, Jaeyeun Lee, et al.
ACS Chemical Neuroscience
|
September 15, 2022
Neuroprotective Effects of σ<sub>2</sub>R/TMEM97 Receptor Modulators in the Neuronal Model of Huntington's Disease
Jing Jin, Nicolas Arbez, James J Sahn, et al.
Pharmaceutics
|
October 27, 2022
D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase II
Sadakatali S Gori, Ajit G Thomas, Arindom Pal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 10, 2026
Glutamate carboxypeptidase II activation in astrocytes mediates glymphatic impairment and cognitive vulnerability in the aging brain following surgery
Yuto Hasegawa, Hiroki Kawai, Robyn Wiseman, et al.
Rapid Communications in Mass Spectrometry : RCM
|
June 12, 2024
Development of a high-throughput dual-stream liquid chromatography-tandem mass spectrometry method to screen for inhibitors of glutamate carboxypeptidase II
Nate Hoxie, Yixuan Qiu, Stephen C Kales, et al.
Nanotheranostics
|
January 3, 2022
Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis
Kristen R Hollinger, Anjali Sharma, Carolyn Tallon, et al.
Frontiers in Pharmacology
|
October 31, 2025
Mass spectrometry-guided discovery of novel GCPII inhibitor scaffolds
Robyn Wiseman, Ajit G Thomas, John Janiszewski, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Advances in Pharmacology (San Diego, Calif.)
|
February 10, 2025
Inhibition of brain glutamate carboxypeptidase II (GCPII) to enhance cognitive function
Robyn Wiseman, Kristin L Bigos, Amy F T Arnsten, et al.
Research Square
|
November 21, 2023
Nelfinavir Inhibition of Kaposi's sarcoma-associated herpesvirus protein expression and capsid assembly
Maggie Li, Barbara Smith, Lee Jaeyeun, et al.
Behavioural Processes
|
September 6, 2023
Degrading stimuli by reducing image resolution impairs performance in a rodent continuous performance test
Adrienne C DeBrosse, Ye Li, Robyn Wiseman, et al.
Infectious Agents and Cancer
|
March 4, 2024
Nelfinavir inhibition of Kaposi's sarcoma-associated herpesvirus protein expression and capsid assembly
Maggie Li, Barbara J Smith, Jaeyeun Lee, et al.
ACS Chemical Neuroscience
|
September 15, 2022
Neuroprotective Effects of σ<sub>2</sub>R/TMEM97 Receptor Modulators in the Neuronal Model of Huntington's Disease
Jing Jin, Nicolas Arbez, James J Sahn, et al.
Pharmaceutics
|
October 27, 2022
D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase II
Sadakatali S Gori, Ajit G Thomas, Arindom Pal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 10, 2026
Glutamate carboxypeptidase II activation in astrocytes mediates glymphatic impairment and cognitive vulnerability in the aging brain following surgery
Yuto Hasegawa, Hiroki Kawai, Robyn Wiseman, et al.
Rapid Communications in Mass Spectrometry : RCM
|
June 12, 2024
Development of a high-throughput dual-stream liquid chromatography-tandem mass spectrometry method to screen for inhibitors of glutamate carboxypeptidase II
Nate Hoxie, Yixuan Qiu, Stephen C Kales, et al.
Nanotheranostics
|
January 3, 2022
Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis
Kristen R Hollinger, Anjali Sharma, Carolyn Tallon, et al.
Frontiers in Pharmacology
|
October 31, 2025
Mass spectrometry-guided discovery of novel GCPII inhibitor scaffolds
Robyn Wiseman, Ajit G Thomas, John Janiszewski, et al.
Page
of 2